Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Already profitable and a lot more to come. This could be gigantic in the near future.
Just after I sold to get a chunk of cash in the ISA, so I have been delighted to top up here today to increase this holding to over the 250000 mark. Medium term I expect these to soar and I am already into a nice profit. Just wish I could say the same about the rest of the p/f!
Investors simply haven't grasped the importance of the RNS yet.
PRM discovery will save the Big Pharmaceuticals millions.
Here is the news released today
TIDMPRM
RNS Number : 2669O
Proteome Sciences PLC
02 October 2023
2 October 2023
Proteome Sciences plc
("Proteome Sciences" or the "Company")
Launch of Commercial Single Cell Proteomics Services
Proteome Sciences plc is pleased to announce the launch of SysQuant(R)
SCP, the commercial service for single cell proteomics using the
power of its TMTpro(TM) isobaric labelling reagents. Where more
traditional approaches can measure a few 10s of proteins on each
cell using antibody labelling, SysQuant(R) SCP can identify more
than 1,000 proteins in each study of 576 single cells and provides
novel insights into individual cell biology and heterogeneity.
Proteome Sciences is one of the first commercial providers of such
studies which are expected to significantly improve the performance
of drug development across multiple diseases including cancer,
neurodegeneration, respiratory and cardiac health, and metabolic
disorders. Whilst in its infancy, the field of single cell proteomics
is expected to grow rapidly as drug developers look to integrate
single cell genomic data with knowledge of protein changes. At
the same time, the complexity of the process along with the need
to purchase and maintain costly equipment represents a significant
barrier to entry.
The SysQuant(R) SCP pipeline generates and analyses quantitative
mass spectrometry data to reveal subtle changes not only in individual
cells but also within sub-populations of that same main cell type.
This data will greatly improve understanding of the biological
drivers of heterogeneity and evolution in the contexts of disease
and response to therapy, which will offer new therapeutic and diagnostic
targets for personalized medicine.
Commenting on the launch of SysQuant(R) SCP, Dr. Ian Pike Chief
Scientific Officer stated:
"This is an important step for Proteome Sciences as we have adapted
cutting-edge techniques developed in academia to make them available
to the pharmaceutical and biotechnology industries through SysQuant(R)
SCP. We have built a robust platform that will provide customers
with transformational data enabling a deeper understanding of disease
biology and how drugs are interacting with their targets. SysQuant(R)
SCP studies are highly complementary to our established workflows
performed on larger samples and open up a new customer base needing
access to this valuable novel single cell information."
Dr. Mariola Soehngen, Chief Executive Officer commented:
"We are pleased to be one of the first CROs providing single cell
proteomics to our customers. The launch of SysQuant(R) SCP is part
of our growth strategy along with the opening of a US facility
in San Diego. We believe that broadening our range of services
and incr
Another Pharma double bagger in the making today.
Why is the rns not showing this morning
Few SBs coming out on this entirely predictable Presentation, no doubt assuming they can get back cheaper in 6 months! But this co has funded expansion out of their own resources (so far) and still stand on the brink of massive successes. Also they should reflect on the rather horrible brokers' turn! But if this does fall off a cliff, I might top up.
...on Tuesday to hear the latest from Mariola. Won't take much by way of positive news to push this sp along again.
...varying the spread here. Obviously as a modest enterprise they, like all others, have been squeezed as the result of the rotten inflation, with materials going up and customers delaying orders and possibly payments. All perfectly understandable. And expanding into USA at this time depletes funds. Hopefully this will recover and still exceed expectations given time. If you aren't into these, might be a good time to tuck a few away.
....not really deserved in this lousy market but I will give this longer.
Yes a dip in earnings don't deserve a 30% drop in share price
I was expecting better, not expecting a dip in earnings
.....double figures shortly when RNS confirms San Diego lab is up and running.
It's nice to see a bit of blue for a change
Info on San Diego must be due soon.
This SP has just dropped 3.7% on the strength of a tiny sell and a 27000 buy! Not long now before I expect an update on our new lab opening in San Diego. That might just pop PRM's head over the parapet and get a bit of interest 10-15p would be nice.
90 mins to a verdict...
Big week ahead -or damp squib?
....within next month or so, the opening for business of the US laboratory in San Diego and double figures for the SP.
Pesky profit takers ..you will regret it ! 🤣
Big and late.
Day after day so many late delayed buys and with a bit of a tree shake this morning i still think we have a long way to go
SP acting exactly as I predicted (as well as this grizzly market!)
This has miles further to rise once the new lab opens in San
Diego (expect July/August). I am not even thinking of selling any [[luckily, I hold quite a few) until they at least double from here.
Yeah copy that! Roger65...the bottom feeders, the shorters, rampers/derampers ..drove through the city on friday pm & i saw them all outside the pubs toasting !..or maybe they where MM!